SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-023274
Filing Date
2017-11-09
Accepted
2017-11-09 16:30:51
Documents
52
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ovid-10q_20170930.htm 10-Q 1670752
2 EX-31.1 ovid-ex311_7.htm EX-31.1 19718
3 EX-31.2 ovid-ex312_8.htm EX-31.2 19824
4 EX-32.1 ovid-ex321_6.htm EX-32.1 7545
  Complete submission text file 0001564590-17-023274.txt   4488826

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ovid-20170930.xml EX-101.INS 756797
6 XBRL TAXONOMY EXTENSION SCHEMA ovid-20170930.xsd EX-101.SCH 33029
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ovid-20170930_cal.xml EX-101.CAL 24922
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ovid-20170930_def.xml EX-101.DEF 110738
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ovid-20170930_lab.xml EX-101.LAB 241773
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ovid-20170930_pre.xml EX-101.PRE 197151
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38085 | Film No.: 171191299
SIC: 2834 Pharmaceutical Preparations